Article metrics

Download PDFPDF

374 A first-in-human Phase 1/2 open label trial evaluating the safety, pharmacology, and preliminary efficacy of VT1021 in subjects with advanced solid tumors

 

Online download statistics by month:

Online download statistics by month: November 2020 to October 2024

AbstractFullPdf
Nov 2020146020
Dec 20203405
Jan 20213005
Feb 20212406
Mar 20214008
Apr 202132011
May 20213104
Jun 2021009
Jul 20210012
Aug 20210011
Sep 20210054
Oct 202150050
Nov 202182024
Dec 20215808
Jan 20225804
Feb 20225006
Mar 202258012
Apr 202270012
May 20224203
Jun 20224601
Jul 202286010
Aug 202274011
Sep 2022112012
Oct 20228208
Nov 20227403
Dec 20227202
Jan 20235403
Feb 20237806
Mar 202392011
Apr 20235205
May 202396010
Jun 202312804
Jul 2023150013
Aug 2023175014
Sep 202312209
Oct 202311402
Nov 202314206
Dec 202314605
Jan 20244604
Feb 20244204
Mar 20244005
Apr 202470013
May 20246404
Jun 20243704
Jul 20243703
Aug 202452011
Sep 20244603
Oct 202452012
Total31860462